ENWEndNote BIBJabRef, Mendeley RISPapers, Reference Manager, RefWorks, Zotero AMA Hołdrowicz A, Narbutt J, Pałczyński C, Kupryś-Lipińska I, Lesiak A. Bullous skin lesion reaction as an example of an adverse effect of a preparation containing 0.1% octenidine dihydrochloride and 2% phenoxyethanol (Octenisept®). Dermatology Review/Przegląd Dermatologiczny. 2018;105(6):753-760. doi:10.5114/dr.2018.80845. APA Hołdrowicz, A., Narbutt, J., Pałczyński, C., Kupryś-Lipińska, I., & Lesiak, A. (2018). Bullous skin lesion reaction as an example of an adverse effect of a preparation containing 0.1% octenidine dihydrochloride and 2% phenoxyethanol (Octenisept®). Dermatology Review/Przegląd Dermatologiczny, 105(6), 753-760. https://doi.org/10.5114/dr.2018.80845 Chicago Hołdrowicz, Agnieszka, Joanna Narbutt, Cezary Pałczyński, Izabela Kupryś-Lipińska, and Aleksandra Lesiak. 2018. "Bullous skin lesion reaction as an example of an adverse effect of a preparation containing 0.1% octenidine dihydrochloride and 2% phenoxyethanol (Octenisept®)". Dermatology Review/Przegląd Dermatologiczny 105 (6): 753-760. doi:10.5114/dr.2018.80845. Harvard Hołdrowicz, A., Narbutt, J., Pałczyński, C., Kupryś-Lipińska, I., and Lesiak, A. (2018). Bullous skin lesion reaction as an example of an adverse effect of a preparation containing 0.1% octenidine dihydrochloride and 2% phenoxyethanol (Octenisept®). Dermatology Review/Przegląd Dermatologiczny, 105(6), pp.753-760. https://doi.org/10.5114/dr.2018.80845 MLA Hołdrowicz, Agnieszka et al. "Bullous skin lesion reaction as an example of an adverse effect of a preparation containing 0.1% octenidine dihydrochloride and 2% phenoxyethanol (Octenisept®)." Dermatology Review/Przegląd Dermatologiczny, vol. 105, no. 6, 2018, pp. 753-760. doi:10.5114/dr.2018.80845. Vancouver Hołdrowicz A, Narbutt J, Pałczyński C, Kupryś-Lipińska I, Lesiak A. Bullous skin lesion reaction as an example of an adverse effect of a preparation containing 0.1% octenidine dihydrochloride and 2% phenoxyethanol (Octenisept®). Dermatology Review/Przegląd Dermatologiczny. 2018;105(6):753-760. doi:10.5114/dr.2018.80845.